Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

336 ARTÍCULOS , VIENDO DEL 61 AL 75

Escitalopram versus risperidone for the treatment of behavioral and psychotic symptoms associated with Alzheimer's disease: a randomized double-blind pilot study

Barak Y, Plopski I, Tadger S, Paleacu D.

Int Psychogeriatr. 2011 Nov;23(9):1515-9. doi: 10.1017/S1041610211000743. Epub 2011 Apr 15.

Delusion of reduplication of tongue accompanied by dangerous self-treatments in a patient with Alzheimer's disease

Hayashi H, Suzuki A, Matsumoto Y, Otani K.

Aust N Z J Psychiatry. 2011 May;45(5):427. doi: 10.3109/00048674.2011.566548.

Persons with mild or moderate Alzheimer's disease use a basic orientation technology to travel to different rooms within a day center

Lancioni GE, Perilli V, Singh NN, O'Reilly MF, Sigafoos J, Bosco A, De Caro MF, Cassano G, Pinto K, Minervini M.

Res Dev Disabil. 2011 Sep-Oct;32(5):1895-901. doi: 10.1016/j.ridd.2011.03.020. Epub 2011 Apr 17.

A phase II trial of huperzine A in mild to moderate Alzheimer disease

Rafii MS, Walsh S, Little JT, Behan K, Reynolds B, Ward C, Jin S, Thomas R, Aisen PS; Alzheimer's Disease Cooperative Study.

Neurology. 2011 Apr 19;76(16):1389-94. doi: 10.1212/WNL.0b013e318216eb7b.

Controlled study on the cognitive and psychological effect of coloring and drawing in mild Alzheimer's disease patients

Hattori H, Hattori C, Hokao C, Mizushima K, Mase T.

Geriatr Gerontol Int. 2011 Oct;11(4):431-7. doi: 10.1111/j.1447-0594.2011.00698.x. Epub 2011 Apr 26.

FDG- and amyloid-PET in Alzheimer's disease: is the whole greater than the sum of the parts?

Mosconi L, McHugh PF.

Q J Nucl Med Mol Imaging. 2011 Jun;55(3):250-64.

Loss of motor function in preclinical Alzheimer's disease

Buchman AS, Bennett DA.

Expert Rev Neurother. 2011 May;11(5):665-76. doi: 10.1586/ern.11.57.

Cerebral autoregulation in Alzheimer's disease

Claassen JA, Zhang R.

J Cereb Blood Flow Metab. 2011 Jul;31(7):1572-7. doi: 10.1038/jcbfm.2011.69. Epub 2011 May 4.

Alzheimer's disease management guideline: update 2008

Segal-Gidan F, Cherry D, Jones R, Williams B, Hewett L, Chodosh J; California Workgroup on Guidelines for Alzheimer's Disease Management.

Alzheimers Dement. 2011 May;7(3):e51-9. doi: 10.1016/j.jalz.2010.07.005. Epub 2011 May 5.

Modeling trajectories and transitions: results from the New York University caregiver intervention

Gaugler JE, Roth DL, Haley WE, Mittelman MS.

Nurs Res. 2011 May-Jun;60(3 Suppl):S28-37. doi: 10.1097/NNR.0b013e318216007d.

Regional grey matter loss and brain disconnection across Alzheimer disease evolution

Bozzali M, Padovani A, Caltagirone C, Borroni B.

Curr Med Chem. 2011;18(16):2452-8. doi: 10.2174/092986711795843263.

Cognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: outcomes from CATIE-AD

Vigen CL, Mack WJ, Keefe RS, Sano M, Sultzer DL, Stroup TS, Dagerman KS, Hsiao JK, Lebowitz BD, Lyketsos CG, Tariot PN, Zheng L, Schneider LS.

Am J Psychiatry. 2011 Aug;168(8):831-9. doi: 10.1176/appi.ajp.2011.08121844. Epub 2011 May 15.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias